Gabliani G, Deligonul U, Kern M J, Vandormael M
Division of Cardiology, St. Louis University Hospital, MO 63104.
Am Heart J. 1988 Sep;116(3):696-700. doi: 10.1016/0002-8703(88)90326-2.
The incidence and prognosis of acute coronary reocclusion occurring after patients had left the catheterization laboratory following a successful percutaneous transluminal coronary angioplasty (PTCA) procedure and the temporal relation of this event to the discontinuation of systemic heparin administration were analyzed in a series of 1238 consecutive patients. Acute reocclusion, 1 to 96 hours after successful PTCA, occurred in 22 of 1238 patients (1.8%). Patients undergoing PTCA in the setting of acute myocardial infarction were excluded. Out of 22 patients, 15 had a nonocclusive dissection and four had evidence of small intracoronary thrombus immediately post-PTCA, with no evidence of flow disturbance. Acute reocclusion occurred within 5 hours of heparin discontinuation in 12 patients or while they were receiving inadequate anticoagulation (four patients). In 16 of 22 (73%) patients, acute reocclusion was temporally related to a time of diminished anticoagulation. Redilation was attempted in 14 patients and was ultimately successful in five patients (36%). Ten patients required coronary artery bypass surgery and three patients died. Our findings suggest that acute reocclusion after an initially successful PTCA has a poor outcome and seems to be temporally related to the loss of effective anticoagulation in most of these patients. It is advisable to discontinue heparin infusion at a time when facilities for urgent revascularization are available.
在一系列连续的1238例患者中,分析了成功进行经皮腔内冠状动脉成形术(PTCA)后患者离开心导管室后发生急性冠状动脉再闭塞的发生率和预后,以及该事件与全身肝素给药停止的时间关系。在成功进行PTCA后1至96小时内,1238例患者中有22例(1.8%)发生急性再闭塞。排除在急性心肌梗死情况下接受PTCA的患者。在22例患者中,15例有非闭塞性夹层,4例在PTCA后即刻有冠状动脉内小血栓证据,但无血流紊乱证据。12例患者在肝素停用后5小时内或接受抗凝不足时(4例患者)发生急性再闭塞。22例患者中有16例(73%)急性再闭塞与抗凝减弱时间相关。14例患者尝试再次扩张,最终5例(36%)成功。10例患者需要冠状动脉搭桥手术,3例患者死亡。我们的研究结果表明,最初成功进行PTCA后发生的急性再闭塞预后较差,且在大多数此类患者中似乎与有效抗凝作用丧失在时间上相关。建议在有紧急血管重建设施时停止肝素输注。